96 related articles for article (PubMed ID: 30570880)
1. In silico CD4+, CD8+ & humoral immunity associated antigenic epitope prediction and HLA distribution analysis of HTLV-I.
Bano T; Mohammed Janahi E; Dhasmana A; Lohani M; Haque S; K Mandal R; A Dar S; Jawed A; Wahid M; Akhter N; Y Areeshi M
J BUON; 2018; 23(5):1514-1527. PubMed ID: 30570880
[TBL] [Abstract][Full Text] [Related]
2. In silico CD4+, CD8+ T-cell and B-cell immunity associated immunogenic epitope prediction and HLA distribution analysis of Zika virus.
Janahi EM; Dhasmana A; Srivastava V; Sarangi AN; Raza S; Arif JM; Bhatt MLB; Lohani M; Areeshi MY; Saxena AM; Haque S
EXCLI J; 2017; 16():63-72. PubMed ID: 28435428
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.
Mulherkar R; Karabudak A; Ginwala R; Huang X; Rowan A; Philip R; Murphy EL; Clements D; Ndhlovu LC; Khan ZK; Jain P
Vaccine; 2018 Aug; 36(33):5046-5057. PubMed ID: 30005946
[TBL] [Abstract][Full Text] [Related]
4. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
[TBL] [Abstract][Full Text] [Related]
5. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
6. Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).
Raza MT; Mizan S; Yasmin F; Akash AS; Shahik SM
PLoS One; 2021; 16(4):e0248001. PubMed ID: 33798232
[TBL] [Abstract][Full Text] [Related]
7. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
8. Quantifying HTLV-I dynamics.
Asquith B; Bangham CR
Immunol Cell Biol; 2007 Jun; 85(4):280-6. PubMed ID: 17372609
[TBL] [Abstract][Full Text] [Related]
9. Predicting and Designing Epitope Ensemble Vaccines against HTLV-1.
Alam S; Hasan MK; Manjur OHB; Khan AM; Sharmin Z; Pavel MA; Hossain MF
J Integr Bioinform; 2020 Jan; 16(4):. PubMed ID: 31913852
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 infections.
Bangham CR
J Clin Pathol; 2000 Aug; 53(8):581-6. PubMed ID: 11002759
[TBL] [Abstract][Full Text] [Related]
11. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
[TBL] [Abstract][Full Text] [Related]
12. Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant.
Kozako T; Hirata S; Shimizu Y; Satoh Y; Yoshimitsu M; White Y; Lemonnier F; Shimeno H; Soeda S; Arima N
FEBS J; 2011 Apr; 278(8):1358-66. PubMed ID: 21332943
[TBL] [Abstract][Full Text] [Related]
13. Recognition of adult T-cell leukemia/lymphoma cells by CD4+ helper T lymphocytes specific for human T-cell leukemia virus type I envelope protein.
Kobayashi H; Nagato T; Yanai M; Oikawa K; Sato K; Kimura S; Tateno M; Omiya R; Celis E
Clin Cancer Res; 2004 Oct; 10(20):7053-62. PubMed ID: 15501985
[TBL] [Abstract][Full Text] [Related]
14. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I.
Hanon E; Stinchcombe JC; Saito M; Asquith BE; Taylor GP; Tanaka Y; Weber JN; Griffiths GM; Bangham CR
Immunity; 2000 Nov; 13(5):657-64. PubMed ID: 11114378
[TBL] [Abstract][Full Text] [Related]
15. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
Jacobson S; Reuben JS; Streilein RD; Palker TJ
J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous proliferation of memory (CD45RO+) and naive (CD45RO-) subsets of CD4 cells and CD8 cells in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II.
Prince HE; York J; Owen SM; Lal RB
Clin Exp Immunol; 1995 Nov; 102(2):256-61. PubMed ID: 7586675
[TBL] [Abstract][Full Text] [Related]
17. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients.
Kozako T; Arima N; Toji S; Masamoto I; Akimoto M; Hamada H; Che XF; Fujiwara H; Matsushita K; Tokunaga M; Haraguchi K; Uozumi K; Suzuki S; Takezaki T; Sonoda S
J Immunol; 2006 Oct; 177(8):5718-26. PubMed ID: 17015761
[TBL] [Abstract][Full Text] [Related]
18. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
Parker CE; Daenke S; Nightingale S; Bangham CR
Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
[TBL] [Abstract][Full Text] [Related]
20. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
